CN Patent
CN110740736A — 预防体-肺动脉分流术血栓形成的方法
Assigned to Chiesi Farmaceutici SpA · Expires 2020-01-31 · 6y expired
What this patent protects
本发明涉及坎格雷洛在经历分流术手术的先天性心脏病患者中治疗和/或预防分流术血栓形成的用途。本发明还涉及坎格雷洛在经历支架植入的儿科患者中治疗和/或预防支架血栓形成的用途。
USPTO Abstract
本发明涉及坎格雷洛在经历分流术手术的先天性心脏病患者中治疗和/或预防分流术血栓形成的用途。本发明还涉及坎格雷洛在经历支架植入的儿科患者中治疗和/或预防支架血栓形成的用途。
Drugs covered by this patent
- Kengreal (CANGRELOR) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.